Search
for
Sort by
Research 541–570 of 1000+
- Polycystic ovary syndrome: An update on diagnosis and management
- Effect of inhibiting prolactin secretion on secondary hair follicle development in cashmere goats
- Drug Repurposing Patent Applications July–September 2025
- Hair Loss in a Hemodialysis Patient after Repetitive Use of the Antipruritic Drug Nalfurafine: Implications of Impaired Angiogenesis for Hair Loss
- Optimized Methodology to Produce Platelet-Rich Plasma and Perform Platelet Aggregation in Patients With Coronary Artery Disease
- Bicalutamide does not raise transaminases in comparison to alternative anti-androgen regimens among transfeminine adolescents and young adults: a retrospective cohort study
- IV Międzynarodowe Sympozjum Studenckich Kół Naukowych Środowisko – Roślina – Zwierzę – Produkt Streszczenia
- In vivo Study of the Effect of 5 and 10% Nebivolol Cream on Hair Growth in Mice Models
- A Summary of Pre-Clinical and Clinical Evidence for Cannabinoid Hair Follicle Effects
- Penis Endocrinology
- PLAU and SerpinB2 role in apoptosis in leprosy
- Pityriasis rubra pilaris unveiling a case of a new onset hepatitis C infection
- 217 The adenosine-generating ecto-enzyme CD73 regulates human hair growth
- 218 Chemokine receptor CCR5 is the novel target for the treatment of alopecia areata
- 559 Visualization of sweat suppression following botulinum toxin A by soluble microneedle arrays
- 554 Repurposing a clinical antimalarial for the therapeutic induction of lethal ER stress targeting BRAF-kinase inhibitor-resistant malignant melanoma
- 557 A peptide derivative with known anti-wrinkle properties was identified as potent dipeptiylpeptidase-4 inhibitor
- Abstract 151
- Minimal systemic exposure of a new topical triazole antifungal, efinaconazole 10% solution, in patients with severe onychomycosis following 28-day treatment
- Lichen planopilaris
- Contents
- Slow progress in prostate cancer
- Contents
- USE OF SPIRONOLACTONE IN COMBINATION WITH AN ORAL CONTRACEPTIVE IN TREATMENT OF HIRSUTISM
- 17α-Acetoxy-6-bromo-16β-methylpregna-4,6-diene-3,20-dione
- Oral contraceptives and risk of breast cancer in women aged 20–54 years
- The dose‐response of percutaneous oestradiol implants on the skeletons of postmenopausal women
- A comparison of cabergoline and bromocriptine in the treatment of hyperprolactinemic amenorrhea
- Drug Information Analysis Service
- The Nuts and Bolts of Low-level Laser (Light) Therapy